Lv51
900 积分 2024-12-14 加入
Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial
2小时前
待确认
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
2小时前
待确认
Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition
2小时前
待确认
Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction
2小时前
待确认
Prognostic role of angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with acute myocardial infarction
2小时前
待确认
Presence of anti-cardiac troponin I antibodies (cTnIAb) and their role in the left ventricular remodelling, in patients with acute myocardial infarction
2小时前
待确认
Spontaneous coronary artery dissection in women with acute myocardial infarction: is there a new role for autoimmunity?
2小时前
求助中
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
2小时前
已完结
Association and predictive value of immunoglobulin and complement levels for incident coronary heart disease: a nested case-control study in Chinese adults
2小时前
已完结
Impact of antiphospholipid and antinuclear antibodies in coronary artery disease progression
2小时前
已完结
皖公网安备34019202002308
